.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cerilliant
Medtronic
Federal Trade Commission
Mallinckrodt
Cantor Fitzgerald
QuintilesIMS
UBS
Cipla
McKinsey

Generated: September 22, 2017

DrugPatentWatch Database Preview

AMNESTROGEN Drug Profile

« Back to Dashboard

Which patents cover Amnestrogen, and when can generic versions of Amnestrogen launch?

Amnestrogen is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in AMNESTROGEN is estrogens, esterified. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estrogens, esterified profile page.

Summary for Tradename: AMNESTROGEN

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list64
Patent Applications: see list9,668
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMNESTROGEN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
AMNESTROGEN
estrogens, esterified
TABLET;ORAL083266-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
AMNESTROGEN
estrogens, esterified
TABLET;ORAL083266-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
AMNESTROGEN
estrogens, esterified
TABLET;ORAL083266-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
AMNESTROGEN
estrogens, esterified
TABLET;ORAL083266-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
AstraZeneca
Medtronic
Citi
Baxter
McKinsey
Merck
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot